AVATAR-2020

计划入组 354 人

The VENTOR Clinical Study

计划入组 25 人 · 首次发布于 2025 年 1 月 6 日

Avatar Contraception Communication Training

计划入组 166 人 · 首次发布于 2023 年 8 月 16 日

MMP13 inhibitors(Alantos Pharmaceuticals)

Campylobacter vaccine (AVANT)

Atherosclerosis vaccine (AVANT Immunotherapeutics)

AVANTOR PERFORMANCE MATERIALS, INC

United States

AVANTOR PERFORMANCE MATERIALS POLAND S A

Poland

Avanos Medical

United States

Avantor's NuSil Expands Partnership with Population Council for Three-Month Dapivirine Vaginal Ring to Advance HIV Prevention

Resonant Clinical Solutions Names Christophe Berthoux as CEO to Drive Global Expansion

CPHI Frankfurt 2025 Reveals Pharma Awards Finalists Highlighting Industry Innovation and Sustainability